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tober 8, 2013.he purpose of this study was to compare the results of acute type A aortic dissection (ATAAD) repair before and
after implementation of a multidisciplinary thoracic aortic surgery program (TASP) at our institution, with dedicated
high-volume thoracic aortic surgeons, a multidisciplinary approach to thoracic aortic disease management, and a
standardized protocol for ATAAD repair.Background Outcomes of ATAAD repair may be improved when operations are performed at specialized high-volume thoracic
aortic surgical centers.Methods Between 1999 and 2011, 128 patients underwent ATAAD repair at our institution. Records of patients who
underwent ATAAD repair 6 years before (n ¼ 56) and 6 years after (n ¼ 72) implementation of the TASP were
retrospectively compared. Expected operative mortality rates were calculated using the International Registry of
Acute Aortic Dissection pre-operative prediction model.Results Baseline risk proﬁles and expected operative mortality rates were comparable between patients who underwent
surgery before and after implementation of the TASP. Operative mortality before TASP implementation was 33.9%
and was statistically equivalent to the expected operative mortality rate of 26.0% (observed-to-expected mortality
ratio 1.30; p ¼ 0.54). Operative mortality after TASP implementation fell to 2.8% and was statistically improved
compared with the expected operative mortality rate of 18.2% (observed-to-expected mortality ratio 0.15; p ¼
0.005). Differences in survival persisted over long-term follow-up, with 5-year survival rates of 85% observed for
TASP patients compared with 55% for pre-TASP patients (p ¼ 0.002).Conclusions ATAAD repair can be performed with results approximating those of elective proximal aortic surgery when
operations are performed by a high-volume multidisciplinary thoracic aortic surgery team. Efforts to standardize
or centralize care of patients undergoing ATAAD are warranted. (J Am Coll Cardiol 2014;63:1796–803)ª 2014 by
the American College of Cardiology FoundationDespite advances in diagnosis and surgical techniques,
operative mortality rates for acute type A aortic dissection
(ATAAD) repair continue to exceed 20% in the United
States and abroad (1–4). However, recent studies have
suggested that outcomes of thoracic aortic surgery may be
improved when operations are performed at high-volume
surgical centers with focused expertise in thoracic aortic
surgery (1,3,5,6). Beginning in July 2005, a thoracic aorticvision of Cardiovascular and Thoracic Surgery,
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revised manuscript received August 29, 2013,surgery program (TASP) was introduced at our institution
based on the hypothesis that performance of operations by a
multidisciplinary aortic surgery team led by dedicated high-
volume thoracic aortic surgeons would lead to improved
outcomes. In this report, we compared the results of
ATAAD repair before and after implementation of the
TASP at our institution.See page 1804Methods
Patient population and data collection. This study was
approved by the institutional review board of Duke Uni-
versity, and the need for individual patient consent was
waived. We retrospectively reviewed the records of all
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1797patients at our institution diagnosed with spontaneously
occurring ATAAD (less than 2 weeks from symptom onset)
6 years before (June 30, 1999 to June 30, 2005) and 6 years
after (July 1, 2005 to July 1, 2011) implementation of the
TASP. Patient records were identiﬁed from the prospec-
tively maintained Duke Thoracic Aortic Surgery Database
(2005 to present) (7–9) as well as from a query of the Duke
Enterprise Data Uniﬁed Content Explorer for all patients
with a discharge diagnosis code (International Classiﬁca-
tion of Diseases-Ninth Revision-Clinical Modiﬁcation) of
441.0 (dissection of aorta) or 441.01 (dissection of aorta,
thoracic). Patients with iatrogenic ATAAD secondary to
cardiac surgery or thoracic endovascular aortic repair were
excluded from the analysis because risk estimation variables
related to hospital presentation could not be ascertained in
cases of iatrogenic ATAAD identiﬁed intraoperatively.
Comorbid conditions and post-operative complications
were deﬁned using Society of Thoracic Surgeons deﬁni-
tions (http://www.sts.org). Long-term follow-up and sur-
vival were assessed from the medical record and the Social
Security Death Index. Individual surgeon ATAAD pro-
cedural volume was calculated by dividing the number of
ATAAD repairs performed by the number of academic
years in which they performed at least 1 ATAAD
operation.
Thoracic aortic surgery program. The multidisciplinary
TASP at Duke University Medical Center includes
cardiothoracic surgery, vascular surgery, cardiac anesthesia,
cardiovascular medicine, cardiac critical care, radiology,
neurology, pathology, medical genetics, blood bank,
nursing, and perfusion specialists. Elective and nonelective
thoracic aortic operations are performed primarily by 2
principal surgeons (G.C.H. and J.G.G.) who received
advanced fellowship training in thoracic aortic surgery.
During the ﬁrst 6 years after program implementation,
520 open proximal thoracic aortic operations (ascending,
root, and/or arch replacement) were performed, for an
average institutional volume of 87 proximal aortic repairs
per year. Before implementation of the TASP, ATAAD
repairs were performed by the general cardiac surgeon on
call.
Patient selection and operative technique. Our current
approach to ATAAD repair represents an adaptation of the
techniques championed by Bavaria et al. in 2001 (10) and
described previously by our group in prior publications (7,8).
Unstable patients (ongoing pain, hemodynamic compromise,
tamponade, or malperfusion) and those who presented
within 48 h of symptom onset were taken emergently to the
operating room for immediate surgical repair. Stable,
asymptomatic patients who arrived more than 48 h after
initial symptom onset underwent urgent operation after
completion of a pre-operative evaluation (5,11,12). Patients
with established visceral malperfusion, especially if static
malperfusion or severe limb ischemia with loss of motor
function, underwent a “complication-speciﬁc approach” in an
attempt to ﬁrst alleviate the malperfusion syndrome (13,14).For patients with debilitating
pre-operative stroke, operation
was delayed by 1 to 2 weeks in
coordination with the neurology
service if the patient was hemo-
dynamically stable without rup-
ture or tamponade. Patients with
uncomplicated acute type A
intramural hematoma with an
ascending aortic diameter less
than 5 cm were managed medi-
cally (15). Operation was deferred
in patients with multisystem or-
gan failure or prohibitive comor-
bidities or in patients undergoing
cardiopulmonary resuscitation with
chest compressions.
All operations were performed by median sternotomy
with intraoperative transesophageal echocardiographic and
invasive hemodynamic monitoring. Methylprednisolone
(1 g intravenously) was administered for pharmacological
neuroprotection to all patients pre-operatively. The stan-
dard operation involved aortic valve resuspension with
ascending aorta and hemi-arch replacement (7,10). Aortic
root replacement was performed selectively for aortic root
aneurysm, intrinsic aortic valve pathology not amenable to
repair, or extensive destruction of the intima of the aortic
root by the dissection process. Total arch replacement was
similarly performed for aneurysm or extensive destruction
of the transverse arch. For hemi-arch or total arch repair,
the open distal anastomosis was completed under a period
of deep hypothermic circulatory arrest with the duration
of cooling guided by electroencephalographic monito-
ring, when available (16). In the unmonitored cases, pa-
tients were cooled for a minimum of 50 min or until
the nasopharyngeal temperature was below 18C (17).
Adjunctive antegrade cerebral perfusion via the right
axillary artery was the preferred cerebral protection strat-
egy in circulatory arrest cases, with retrograde cerebral
perfusion being used in cases in which the right axillary
artery was not suitable for cannulation, as previously
described (7). Transfusion practices were performed as
previously described, with intraoperative low-dose re-
combinant activated factor VII (rFVIIa) administered to
patients with severe coagulopathy refractory to routine
transfusions (7–9).
Statistical analysis. Categorical variables were represented
as number and percent, and continuous variables were rep-
resented by mean, SD, and range. Predicted surgical mor-
tality was calculated using the International Registry of
Acute Aortic Dissection (IRAD) pre-operative prediction
model (18). Estimates of long-term survival were calculated
for all patients using the Kaplan-Meier method and
compared between eras using the log-rank test. The Fisher
exact test was used for all other statistical comparisons,
including comparisons of observed and expected mortality
Table 1 Baseline Characteristics
Variable
Pre-TASP
(n ¼ 56)
TASP
(n ¼ 72) p Value
Age, yrs 58  15 (20–83) 54  14 (20–87) 0.13
Male 39 (70) 52 (72) 0.75
White race 31 (55) 42 (58) 0.74
Body mass index, kg/m2 28  6 (16-48) 29  6 (17-52) 0.35
Hypertension 46 (82) 57 (79) 0.67
Hyperlipidemia 16 (29) 26 (36) 0.37
Active or recent
tobacco use
23 (41) 38 (53) 0.19
Diabetes 5 (9) 2 (3) 0.13
Coronary artery disease 8 (14) 14 (19) 0.44
History of prior stroke 4 (7) 7 (10) 0.61
Chronic obstructive
pulmonary disease
4 (7) 6 (8) 0.80
Baseline creatinine
>1.5 mg/dl
7 (13) 17 (24) 0.11
Peripheral vascular
disease
2 (4) 4 (6) 0.60
Connective tissue disease 7 (13) 7 (10) 0.62
Prior aortic surgery 7 (13) 3 (4) 0.08
Dissection type 0.56
DeBakey type 1 40 (71) 48 (67)
DeBakey type 2 16 (29) 24 (33)
Transfer from outside
institution
40 (71) 55 (76) 0.52
Values are mean  SD (range) or n (%).
TASP ¼ thoracic aortic surgery program.
Table 2
International Registry of Acute Aortic Dissection
Pre-operative Prediction Model Variables
Variable Pre-TASP TASP p Value
Operative patients n ¼ 56 n ¼ 72
Age 70 yrs 13 (23) 10 (14) 0.17
History of aortic valve
replacement
3 (5) 1 (1) 0.20
Presenting hypotension,
shock, or tamponade
9 (16) 6 (8) 0.18
Migrating chest pain 49 (88) 64 (89) 0.81
Pre-operative cardiac
tamponade
4 (7) 5 (7) 0.97
Any pulse deﬁcit 15 (27) 21 (30) 0.77
ECG infarct, new Q waves,
ST-segment elevation,
or ischemia
5 (9) 1 (1) 0.05
Expected operative mortality 26%  29%
(4%–100%)
18%  18%
(4%–84%)
0.36
Nonoperative patients n ¼ 10 n ¼ 12
Age 70 years 9 (90) 2 (17) 0.001
History of aortic valve
replacement
1 (10) 0 0.26
Presenting hypotension,
shock, or tamponade
3 (30) 6 (50) 0.34
Migrating chest pain 8 (80) 6 (50) 0.15
Pre-operative cardiac
tamponade
3 (30) 4 (33) 0.87
Any pulse deﬁcit 0 7 (58) 0.003
ECG infarct, new Q waves,
ST-segment elevation,
or ischemia
0 1 (8) 0.35
Expected operative mortality 46%  40%
(8%–100%)
42%  37%
(4%–98%)
0.53
Values are n (%) or mean  SD (range).
ECG ¼ electrocardiogram; other abbreviation as in Table 1.
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(StataCorp, College Station, Texas).
Results
Patient presentation. Between July 1999 and July 2011,
150 patients at our institution were diagnosed with
ATAAD, of whom 128 (85%) underwent operative repair.
Of these, 56 underwent repair before and 72 underwent
repair after implementation of the TASP. Baseline charac-
teristics of the operative cohort are shown in Table 1. No
statistically signiﬁcant differences in demographic or co-
morbid characteristics were noted between the pre-TASP
and TASP groups.
Expected operative mortality. The IRAD pre-operative
prediction model was used to calculate expected operative
mortality rates for the operative and nonoperative patient
cohorts before and after implementation of the TASP
(Table 2). Expected operative mortality was similar between
eras for operative patients as well as for nonoperative patients
who declined surgery, died prior to surgery, or in whom
operation was deferred.
Operative details. Operative parameters are shown in
Table 3. Fewer TASP patients underwent emergent surgery
and fewer underwent surgery during the night. Several
important differences in operative technique were further
observed between eras, with a higher proportion of arch
replacements, aortic valve resuspensions, and nonmechanical
aortic root replacements performed in the TASP era.Concomitant procedures were less common in the TASP era
primarily due to a decreased proportion of patients under-
going concomitant coronary artery bypass grafting, and
mean cardiopulmonary bypass (CPB) time was reduced by
20%. A higher proportion of cases used circulatory arrest in
the TASP era, and the circulatory arrest cases employed
lower cooling temperatures, shorter circulatory arrest times,
and increased use of selective cerebral perfusion when
compared with the pre-TASP era. Use of rFVIIa was
restricted to the TASP era and was administered intra-
operatively in 27 (38%) and post-operatively in 3 (4%)
TASP patients.
Outcomes. The 30-day/in-hospital adverse events are lis-
ted in Table 4. Signiﬁcant reductions in the rates of reop-
eration for bleeding, delayed sternal closure, and operative
mortality were observed between the TASP and pre-TASP
eras. Operative mortality before TASP implementation was
33.9% and was statistically equivalent to the IRAD-
predicted mortality rate of 26.0% (observed-to-expected
mortality ratio 1.30; p ¼ 0.54) (Fig. 1). Five deaths occurred
intraoperatively, and the causes of death were hemorrhage in
5, withdrawal of care due to severe neurological injury in 5,
cardiac arrest in 3, multisystem organ failure in 3, failure to
wean from CPB in 2, and ruptured descending aorta in 1.
Table 3 Operative Parameters
Variable
Pre-TASP
(n ¼ 56)
TASP
(n ¼ 72) p Value
Case status 0.04
Urgent 6 (11) 18 (25)
Emergent 50 (89) 54 (75)
Operation within 24 h of symptoms 39 (70) 49 (68) 0.85
Operation beginning at night (5 PM–6 AM) 27 (48) 21 (29) 0.03
Redo sternotomy 7 (13) 8 (11) 0.81
Ascending aorta replacement 55 (98) 72 (100) 0.26
Arch replacement 14 (25) 70 (97) <0.0001
Arch type 0.52
Hemi-arch 14 (25) 68 (94)
Total arch 0 2 (3)
Aortic valve resuspension 22 (39) 55 (76) <0.0001
Aortic valve replacement 12 (21) 0 <0.0001
Aortic valve repair 0 4 (6) 0.07
Aortic root replacement 16 (29) 17 (24) 0.52
Root type 0.001
Valve sparing (David-V) 0 6 (8)
Mechanical composite 15 (27) 4 (6)
Stentless bioprosthetic 0 4 (6)
Pericardial composite 1 (2) 3 (4)
Concomitant procedure 21 (38) 12 (17) 0.008
Coronary artery bypass grafting 16 (29) 8 (11)
Mitral valve replacement 1 (2) 0
Mitral valve repair 1 (2) 0
Maze procedure 1 (2) 0
Innominate bypass 2 (4) 0
Aortic arch debranching 0 1 (1)
Descending thoracic aortic endograft 0 1 (1)
Atrial septal defect closure 0 1 (1)
Pulmonary artery embolectomy 0 1 (1)
Femoral bypass 1 (2) 1 (1)
Extracorporeal membrane oxygenation 1 (2) 0
Aortic cross-clamp time, min 128  50 (47–301) 122  37 (48–250) 0.62
Cardiopulmonary bypass time, min 270  94 (107–665) 214  48 (78–377) <0.0001
Use of circulatory arrest 38 (68) 70 (97) <0.0001
Nadir NP temperature, C 16.3  1.4 (12.0–19.0) 14.6  1.9 (11.0–19.0) <0.0001
Circulatory arrest time, min 33  12 (12–53) 25  8 (13–61) 0.002
Selective cerebral perfusion 26 (68) 70 (100) <0.0001
Antegrade cerebral perfusion 5 (13) 67 (96)
Retrograde cerebral perfusion 21 (55) 3 (4)
Recombinant activated factor VII use 0 30 (42) <0.0001
Values are n (%) or mean  SD (range).
NP ¼ nasopharyngeal; other abbreviation as in Table 1.
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1799Operative mortality after TASP implementation fell to
2.8% and was statistically improved compared with the
IRAD-predicted mortality rate of 18.2% (observed-to-
expected mortality ratio 0.15; p ¼ 0.005) (Fig. 1). No pa-
tients died intraoperatively, and the causes of death included
cardiac arrest in 1 and acute myocardial infarction in 1.
Differences in survival persisted over long-term follow-up,
with 5-year survival rates of 85% observed for TASP pa-
tients (mean follow-up 52  23 months) compared with
55% for pre-TASP patients (mean follow-up 104  38
months) (Fig. 2).Surgeon-speciﬁc procedural volume and outcomes.
During the 6-year period prior to TASP implementation, an
average of 9 ATAAD repairs were performed per year at the
institution. These operations were performed by 11 different
surgeons with average annual procedural volumes of 2.0
 1.3 ATAAD repairs/year (range 1 to 4 ATAAD repairs/
year). Surgeon-speciﬁc mortality rates ranged from 20% to
67% for the 8 surgeons who performed more than 1
ATAAD operation during the study period (Fig. 3). During
the ﬁrst 6 years after TASP implementation, an average of
12 ATAAD repairs were performed per year at the
Table 4 30-Day/In-Hospital Adverse Events
Complication
Pre-TASP
(n ¼ 56)
TASP
(n ¼ 72) p Value
Reoperation for bleeding 11 (19.6) 3 (4.2) 0.005
Delayed sternal closure 6 (10.7) 1 (1.4) 0.02
Deep sternal wound
infection
2 (3.6) 2 (2.8) 0.80
Acute renal failure
(Cr >2.0 mg/dl
and >2  baseline)
15 (26.8) 12 (16.7) 0.16
New-onset dialysis 4 (7.1) 4 (5.6) 0.71
Prolonged ventilation
(> 24 h)
16 (28.6) 15 (20.8) 0.31
Tracheostomy 5 (8.9) 6 (8.3) 0.91
Myocardial infarction 1 (1.8) 1 (1.4) 0.86
Stroke (neurologic deﬁcit
lasting >72 h)
7 (12.5) 4 (5.6) 0.16
Post-operative length
of stay, days
10  12 (0–55) 12  12 (4–69) 0.05
30-day/in-hospital death 19 (33.9) 2 (2.8) <0.0001
Values are mean  SD (range) or n (%).
Cr ¼ creatinine; other abbreviation as in Table 1.
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1800institution. Seventy (97%) of these cases were performed by
the 2 principal TASP surgeons, of whom surgeon 12 per-
formed an average of 9.7 ATAAD repairs/year with a
surgeon-speciﬁc mortality rate of 1.7% and surgeon 13
performed an average of 4.0 ATAAD repairs/year with a
surgeon-speciﬁc mortality rate of 8.3% (Fig. 3).Discussion
In this single-center experience, we demonstrated a sig-
niﬁcant reduction in operative mortality for ATAAD
repair following the implementation of a TASP with de-
dicated high-volume thoracic aortic surgeons, a multidis-
ciplinary approach to thoracic aortic disease management,
and a standardized protocol for ATAAD repair. TheFigure 1
Observed and Expected Operative Mortality Rates for
Acute Type A Aortic Dissection Repaircontemporary operative mortality rate of 2.8% appears
improved compared with cumulative operative mortality
rates reported by national and international registries
(1–3,19) but similar to other experienced aortic centers
where operative mortality rates below 10% have been ach-
ieved (10,20–22).
Although patient characteristics and expected operative
mortality rates were statistically equivalent between eras,
there were several important differences in patient risk
proﬁles that likely inﬂuenced outcomes. Speciﬁcally, TASP
patients were noted to be younger and had decreased rates of
hypotension, shock, tamponade, and myocardial infarction
at presentation compared with pre-TASP patients. Corre-
spondingly, the expected operative mortality for TASP
patients was numerically lower than for pre-TASP patients
(18.2% vs. 26.0%). As a result, the observed-to-expected
mortality improved only 9-fold after TASP introduction
(0.15 vs. 1.30), whereas raw mortality rates improved by
12-fold (2.8% vs. 33.9%), suggesting that the reduction in
operative mortality was partially due to operation on lower-
risk patients. However, deferral of surgery in high-risk
patients did not appear to be the underlying source of the
reduced operative risk, given that the rate of nonoperation
remained unchanged at 15% and the predicted mortality
of the nonoperative patients was nearly identical between
eras. In addition, the rates of medical management in our
series were similar to those reported in the IRAD database
(9.9% to 28%), suggesting that our selection criteria were not
overly selective (19,23). However, these data highlight that
patient selection and differences in baseline risk are powerful
drivers of outcomes that must be objectively assessed when
comparing outcomes between centers and studies.
One of the most important advances following imple-
mentation of the TASP was the modernization and stan-
dardization of operative technique and cerebral protection
strategies. Prior to the TASP, marked variability in operative
technique and circulation management was observed. Dur-
ing this period, the rate of stroke was 12.5% and 5 deaths
(8.9%) were the consequence of unrecoverable neurological
injury. Essential additions to our modern operative strategy
included right axillary cannulation, root replacement for
standardized indications, routine hemi-arch reconstruction,
use of circulatory arrest with deep hypothermia, electroen-
cephalographic monitoring when available, and antegrade
cerebral perfusion as the preferred cerebral protection
adjunct. With these measures, the rate of stroke was 5.6%
and no deaths resulted from neurological injury.
The second major area of improvement following
implementation of the TASP was reduced morbidity and
mortality from bleeding complications. Prior to TASP im-
plementation, nearly a quarter of patients underwent reop-
eration for bleeding and/or delayed sternal closure and
5 patients (8.9%) succumbed to refractory hemorrhage. In
the modern cohort, rates of reoperation for bleeding and
delayed sternal closure were signiﬁcantly reduced and no
patients died of hemorrhage. These improvements are likely
Figure 2 Kaplan-Meier Estimates of Survival Stratiﬁed by Era
N ¼ number at risk; SE ¼ standard error.
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1801attributable to the advent of intraoperative low-dose rFVIIa
protocols as well as standardization and optimization of
transfusion maneuvers with deep hypothermia (8,9).Figure 3 Distribution of Surgeons Performing Acute Type A Aortic D
Between 1999 and 2011, 128 acute type A aortic dissection repairs were performed byThe timing and expediency of surgery were also noted to
change signiﬁcantly between erasdthe proportion of cases
initiated at night decreased from 48% to 29% and the
number of emergent cases decreased from 89% to 75%
during the TASP era. It is our current practice to defer
surgery until daylight hours in stable patients who present
more than 48 h after symptom onset, given the low rate
of rupture or acute decompensation in these patients (5).
There are several theoretical beneﬁts of such an approach,
including performance of a thorough pre-operative evalua-
tion as well as embarking upon these challenging operations
with the most qualiﬁed ancillary team members and without
the undue effects of sleep deprivation on all participants.
Despite these beneﬁts, we continue to operate emergently
on patients who present within 48 h of symptom onset, even
if asymptomatic and stable, given the increased risk of death
within this time frame as well as medicolegal considerations
(5,12).
Lastly, our data provide additional support to the growing
body of literature suggesting that outcomes of proximal
aortic operations are improved when performed by high-
volume centers and high-volume surgeons. Hospital proce-
dure volume has been strongly associated with post-operative
mortality for a number of complex cardiovascular proce-
dures, including both elective and emergent proximal aortic
operations (1,3,6). Although our institutional ATAAD
repair case volumes between 9 and 12 per year may appear
modest, a review of the Nationwide Inpatient Sample
(NIS) by Knipp et al (1) deﬁned high-volume centers as
those that performed more than 2.5 cases per year, and
only 15 NIS-participating centers in the entire country
averaged more than 10 ATAAD repairs per year. How-
ever, in an updated NIS study of aortic dissection repair,
the lowest operative mortality rate of 16.4% was achievedissection Repairs Over Time
13 different surgeons. Open circles ¼ survivors and black diamonds ¼ deaths.
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repairs per year (although both type A and type B repairs
were included in the analysis) (3). Given that our program
achieved a substantially lower mortality rate without
signiﬁcantly exceeding this volume threshold, we suspect
the total number of all proximal aortic cases performed
yearly is likely a better predictor of outcomes than the
number of isolated ATAAD repairs performed. No prior
volume-outcomes study of ATAAD repair has explored
this hypothesis.
Interestingly, the improvement in outcomes observed
before and after TASP implementation occurred without a
marked increase in institutional ATAAD case volume,
suggesting that the more important component of the
volume-outcomes relationship may be surgeon volume (3).
Prior to the TASP, surgeon coverage for aortic emergencies
was provided by the full complement of cardiothoracic sur-
geons, many of whom were without expertise or recent
experience in thoracic aortic surgery and performed only 1 or
2 ATAAD repairs per year. Following implementation of
the TASP, ATAAD repairs were restricted to 2 high-
volume aortic surgeons; as a result, surgeon case volumes
increased substantially for each of the 2 principal surgeons.
Further, the same 2 surgeons also performed all of the
elective proximal aortic operations, dramatically increasing
each surgeon’s yearly proximal aortic case numbers. We
suspect this supersubspecialization in proximal aortic surgery
may be the major contributor to our improved results by
leading to fewer technical errors, shorter CPB and circula-
tory arrest times, more complex root and arch operations,
and avoidance of intraoperative deaths. Creation of similar
programs with designated aortic surgeons at other tertiary
centers may therefore represent an important way to improve
outcomes for this disease process.
The current study and others further suggest that out-
comes of ATAAD repair could be improved through
centralization of care, possibly through the credentialing and
designation of regional referral centers for aortic emergencies
and establishment of protocols for rapid patient transport,
given that few centers are likely to achieve the center and
surgeon volume thresholds associated with the best out-
comes. Although emergent operations are generally con-
sidered less amenable to triage and transfer, most patients
with ATAAD are able to be stabilized and survive transfer, as
evidenced by the approximately 75% of patients in our series
and others who were transferred from other institutions (5).
In addition, a framework for such an enterprise that could
serve as a template for other regions was recently described by
Harris et al. (24) who developed a laudable community
outreach program at more than 30 regional hospitals to
expedite transfer of aortic dissection patients to an aortic
referral center in Minneapolis, Minnesota. This initiative
resulted in signiﬁcant reductions in time to diagnosis,
transfer, and surgery for patients with ATAAD (24).
Study limitations. Several limitations of this study should
be acknowledged. TASP patients were compared withhistorical controls from the era immediately preceding pro-
gram implementation. Therefore, unmeasured confounders
related to patient selection and disease severity at presenta-
tion may inﬂuence the comparison of results between eras.
A selection bias may further exist with regard to patients
who were not accepted for transfer or died during transfer.
The study is prone to type II error and is underpowered to
detect small differences in outcomes between groups.
Finally, results may not be generalizable to other institutions
due to unique differences in patient populations, practi-
tioners, and locoregional factors.Conclusions
This study demonstrated that ATAAD repair can be per-
formed with results approximating those of elective proximal
aortic surgery when operations are performed by a high-
volume multidisciplinary thoracic aortic surgery team.
These data suggest that efforts to standardize or centralize
care of ATAAD patients are warranted.Reprint requests and correspondence: Dr. G. Chad Hughes,
Aortic Surgery Program, Duke University Medical Center, Divi-
sion of Cardiovascular and Thoracic Surgery, Box 3051, Durham,
North Carolina 27710. E-mail: gchad.hughes@duke.edu.REFERENCES
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